Asthma therapy: present trends and future prospects.

Area of Science:

• Pulmonology
• Pharmacology
• Allergy & Immunology

Background:

• Traditional short-term asthma treatments include oxygen, IV theophylline, and inhaled/subcutaneous beta-adrenergic agonists, anticholinergics, and corticosteroids.
• The core components of asthma treatment have remained consistent over time.

Purpose of the Study:

• To review advancements in asthma pharmacotherapy, focusing on improved drug specificity and administration methods.
• To highlight the growing role of inhalation therapy in asthma management.

Main Methods:

• Review of current and emerging asthma treatment strategies.
• Discussion of drug delivery systems, particularly metered-dose inhalers.
• Exploration of novel therapeutic targets and drug classes.

Main Results:

• Metered-dose inhalers enable direct topical delivery of medications to airway mucosa, significantly reducing systemic side effects.
• Inhalation therapy is increasingly recognized as a potentially primary treatment modality for asthma, even in emergency settings.
• Newer beta 2-adrenergic agonists with enhanced selectivity and longer durations of action are available, with ongoing research into bronchodilating corticosteroids, calcium-channel blockers, prostaglandins, leukotrienes, and oral mast-cell stabilizers.

Conclusions:

• Advancements in drug specificity and delivery systems, especially metered-dose inhalers, are transforming asthma care.
• Inhalation therapy is poised to become a cornerstone of asthma management, offering improved efficacy and safety.
• Future research directions include developing more selective bronchodilators and exploring novel delivery routes like transdermal medication.